Article
The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
Cancer cytopathology - 1 Jul 2022
Tao Xiang, Zhang Huina, Zhang Hao, Xiao Yaoxing, Zhong Fangfang, Zhou Xianrong, Cong Qing, Sui Long, Zhao Chengquan
Abstract excerpt
BACKGROUND: The value of extended high-risk human papillomavirus (hrHPV) genotyping for cervical cancer screening in women with low-grade squamous intraepithelial lesion (L-SIL) cytology has been recognized, but few studies have investigated this. METHODS: Women with L-SIL Papanicolaou results who underwent human papillomavirus (HPV) genotyping between October 2017 and October 2021 at the Obstetrics and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
